IHC-plus(tm) NOVA1 Antibody (aa121-134)

LifeSpan BioSciences

IHC-plus(tm) NOVA1 Antibody (aa121-134)

23

Immunohistochemistry: LS-B3259 was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for LS-B3259 was determined to be 2.5 ug/ml.. IHC, IHC-P (2.5 µg/ml), Peptide-ELISA (1:64000), WB (0.01 - 0.03 µg/ml) Immunohistochemistry: LS-B3259 was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for LS-B3259 was determined to be 2.5 ug/ml.

Western Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin

Research Use Only

Polyclonal

0.5 mg/ml

Unconjugated

NOVA1

NOVA alternative splicing regulator 1

Nova-1, RNA-binding protein Nova-1, neuro-oncological ventral antigen 1, onconeural ventral antigen 1, paraneoplastic Ri antigen, ventral neuron-specific protein 1

Goat

Bovine, Canine, Chicken, Human, Mammals, Monkey, Mouse, Porcine, Rabbit, Rat, Xenopus

-20°C

41116161